<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02260570</url>
  </required_header>
  <id_info>
    <org_study_id>D0825-I</org_study_id>
    <secondary_id>1I01RX000825-01</secondary_id>
    <nct_id>NCT02260570</nct_id>
  </id_info>
  <brief_title>Remediation of Impaired Self-Regulation in Patients With Mild TBI</brief_title>
  <official_title>Remediation of Impaired Self-Regulation in Patients With Mild TBI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Berkeley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ability to regulate impulses enables us to plan for the future, to maintain focus in the
      face of distractions (i.e. to encode memories), and to manage emotions. This self regulation
      can be compromised in individuals who have a history of mild traumatic brain injury and
      co-occurring disorders. In this study the investigators are using functional MRI scanning to
      understand how memory and self regulation are expressed in the brains of people with a
      history of mild traumatic brain injury. The investigators are also testing whether the
      medication tolcapone may improve memory and self regulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized, double-blind, placebo-controlled, crossover cognitive neuroscience study,
      the investigators are evaluating whether the COMT inhibitor tolcapone impacts memory and self
      regulation, as measured both behaviorally (via cognitive testing) and neurophysiologically
      (via functional MRI).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2015</start_date>
  <completion_date type="Anticipated">June 29, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 29, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Oxygen Level Dependent (BOLD) brain signal measured using functional MRI</measure>
    <time_frame>Approximately 60-240 minutes following tolcapone/placebo administration</time_frame>
    <description>BOLD signal provides an indirect measure of brain activity during cognitive testing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Performance on Cognitive Testing</measure>
    <time_frame>Approximately 60-240 minutes following tolcapone/placebo administration</time_frame>
    <description>Tasks to assess cognition will be performed while subjects are in the MRI scanner</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Mild Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Functional MRI Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This cognitive science study consists of a single &quot;arm&quot; in which all subjects receive both tolcapone and placebo in randomized, double-blind, counterbalanced, crossover fashion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tolcapone</intervention_name>
    <description>COMT Inhibitor</description>
    <arm_group_label>Functional MRI Arm</arm_group_label>
    <other_name>Tasmar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A pill that contains no active ingredient</description>
    <arm_group_label>Functional MRI Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Veteran ages 18-50 and in general good health;

          -  Able to read English at a 6th grade level;

          -  Able to provide written informed consent;

          -  Normal or corrected to normal visual acuity;

          -  Stable doses of all medications (2 weeks or greater);

          -  History of mild traumatic brain injury greater than 6 months prior to participation

        Exclusion Criteria:

          -  Contraindications to MRI scanning;

          -  Inability to complete basic fMRI requirements;

          -  History of brain surgery or penetrating brain injury;

          -  Uncontrolled blood pressure (low or high);

          -  Contraindications to tolcapone use;

          -  Use of medications or drugs with dopamine-related actions within 30 days;

          -  Active substance abuse or dependence;

          -  Clinically severe medical illness requiring treatment;

          -  History of psychiatric hospitalization (past 1 year) or suicide attempt (past 5
             years);

          -  Seizures greater than 4 weeks after TBI event or seizures requiring active treatment;

          -  History of brain tumor, stroke, Alzheimer's disease, aneurysm rupture, or multiple
             sclerosis;

          -  History of schizophrenia, ADHD or psychiatric diagnosis EXCEPT depression or PTSD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew S Kayser, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Northern California Health Care System, Mather, CA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew S Kayser, MD PhD</last_name>
    <phone>(925) 372-2059</phone>
    <email>andrew.kayser@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>VA Northern California Health Care System, Mather, CA</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew S Kayser, MD PhD</last_name>
      <phone>925-372-2059</phone>
      <email>andrew.kayser@va.gov</email>
    </contact>
    <investigator>
      <last_name>Andrew S Kayser, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kayser AS, Allen DC, Navarro-Cebrian A, Mitchell JM, Fields HL. Dopamine, corticostriatal connectivity, and intertemporal choice. J Neurosci. 2012 Jul 4;32(27):9402-9. doi: 10.1523/JNEUROSCI.1180-12.2012.</citation>
    <PMID>22764248</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2014</study_first_submitted>
  <study_first_submitted_qc>October 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2014</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>concussion</keyword>
  <keyword>traumatic brain injury</keyword>
  <keyword>MRI</keyword>
  <keyword>memory</keyword>
  <keyword>tolcapone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tolcapone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

